Elucidation of the Mechanisms of Human cathelicidin-derived Antimicrobial Peptides (LL-37 and its Truncated LL-31) Against Burkholderia Pseudomallei

被引:0
|
作者
Onanong Phophetleb
Wonn Shweyi Thet Tun
Sompong Klaynongsruang
Sakda Daduang
Suwimol Taweechaisupapong
Rina Patramanon
机构
[1] Khon Kaen University,Department of Biochemistry, Faculty of Science
[2] Khon Kaen University,Protein and Proteomics Research Group
[3] Khon Kaen University,Department of Chemistry, Faculty of Science
[4] Khon Kaen University,Faculty of Pharmaceutical Sciences
[5] Khon Kaen University,Melioidosis Research Center
[6] Khon Kaen University,Biofilm research group, Faculty of Dentistry
关键词
antimicrobial peptides; LL-37 and LL-31; Melioidosis;
D O I
暂无
中图分类号
学科分类号
摘要
Melioidosis is an endemic disease caused by Burkholderia pseudomallei found in tropical areas. The bacterium is intrinsically resistant to conventional antibiotics, making treatment difficult. Cathelicidin-derived peptides LL-37, and its truncated LL-31 played a crucial role in innate immune defense against infected microorganisms. LL-31 showed superior killing activity than LL-37 in reducing bacteria viability, combination with antibiotic ceftazidime (CAZ), outer and inner membrane permeabilization, membrane depolarization, and affinity binding to lipopolysaccharide (LPS) of B. pseudomallei. Both peptides had similar content of alpha-helical structure. This study provided insights into the molecular mechanisms of LL-37 and its truncated form, LL-31. By utilizing the knowledge gained from this study, researchers may be able to improve treatment options and help combat the spread of antibiotic-resistant bacteria.
引用
收藏
相关论文
共 50 条
  • [21] The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
    Babikir, Ibrahim H.
    Abugroun, Elsir A.
    Bilal, Naser Eldin
    Alghasham, Abdullah Ali
    Abdalla, Elmuataz Elmansi
    Adam, Ishag
    BMC INFECTIOUS DISEASES, 2018, 18
  • [22] Dermcidin -: derived peptides show a different mode of action against Staphylococcus aureus than the cathelicidin LL-37
    Senyuerek, I.
    Kalbacher, H.
    Peschel, A.
    Schittek, B.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 269 - 269
  • [23] Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections
    van der Does, Anne M.
    Bergman, Peter
    Agerberth, Birgitta
    Lindbom, Lennart
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (04) : 735 - 742
  • [24] Cathelicidin antimicrobial peptide LL-37 enables uptake of dsDNA into human epidermal keratinocytes
    Dombrowski, Y.
    Peric, M.
    Koglin, S.
    Ruzicka, T.
    Besch, R.
    Schauber, J.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 179 - 179
  • [25] High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli
    Ján Krahulec
    Marcela Hyršová
    Stanislav Pepeliaev
    Jana Jílková
    Zbyněk Černý
    Jana Machálková
    Applied Microbiology and Biotechnology, 2010, 88 : 167 - 175
  • [26] The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds
    Duplantier, Allen J.
    van Hoek, Monique L.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [27] High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli
    Krahulec, Jan
    Hyrsova, Marcela
    Pepeliaev, Stanislav
    Jilkova, Jana
    Cerny, Zbynek
    Machalkova, Jana
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2010, 88 (01) : 167 - 175
  • [28] Generation of Novel Bone Forming Cells (Monoosteophils) from the Cathelicidin-Derived Peptide LL-37 Treated Monocytes
    Zhang, Zhifang
    Shively, John E.
    PLOS ONE, 2010, 5 (11):
  • [29] Mechanisms of cell death induced by the neutrophil antimicrobial peptides α-defensins and LL-37
    Aarbiou, J
    Tjabringa, GS
    Verhoosel, RM
    Ninaber, DK
    White, SR
    Peltenburg, LTC
    Rabe, KF
    Hiemstra, PS
    INFLAMMATION RESEARCH, 2006, 55 (03) : 119 - 127
  • [30] Mechanisms of cell death induced by the neutrophil antimicrobial peptides α-defensins and LL-37
    J. Aarbiou
    G. S. Tjabringa
    R. M. Verhoosel
    D. K. Ninaber
    S. R. White
    L. T. C. Peltenburg
    K. F. Rabe
    P. S. Hiemstra
    Inflammation Research, 2006, 55 : 119 - 127